在类风湿性关节炎中间歇性肺病进展的预后因素:甲状腺可以预防进展吗?
M Ekici1, Y Baytar2, A Akdoğan1
1Department of Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Scandinavian journal of rheumatology
|July 25, 2024
概括
甲托雷克萨特的使用与类风湿性关节炎 (RA) 患者间歇性肺病 (ILD) 进展的减缓有关. 这一发现表明,在RA-ILD中甲醇具有保护作用,需要进一步调查.
科学领域:
- 类风湿病学 类风湿病学
- 肺部病理学 肺部病理学
- 放射学 放射学是一门学科.
背景情况:
- 类风湿性关节炎 (RA) 可以导致间歇性肺病 (ILD),这是导致发病率和死亡率的重要原因.
- 肺部计算机断层扫描 (CT) 对于检测和监测RA相关的ILD (RA-ILD) 进展至关重要.
- 识别与RA-ILD进展相关的因素对于患者管理至关重要.
研究的目的:
- 为了比较RA-ILD患者具有和没有放射性进展的特征,使用肺部CT.
- 确定RA-ILD进展的风险因素和防护因素.
主要方法:
- 追溯观察性研究分析了104名RA-ILD患者的肺部CT扫描.
- 放射性进展定义为区域参与度增加或连续CT扫描结果恶化.
- 后勤回归分析以确定与进展相关的因素.
主要成果:
- 在41.3%的患者中观察到放射性进展.
- 男性性别,ILD的阳性胸部X射线发现,ILD诊断时的50岁以上,CT上的地面玻璃不透明度与进展有关.
- 男性性别和阳性胸部X射线发现是独立的危险因素;甲状腺素使用是独立的保护因素.
结论:
- 甲托雷克萨特的使用与RA患者的ILD进展有负面关联.
- 需要进一步的研究来证实甲状腺在RA-ILD中的保护作用.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
149
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
149
T Cell Types and Functions
986
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
986
Pulmonary Tuberculosis I
228
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
228
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
126
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
126
The JAK-STAT Signaling Pathway
8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.8K


